COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signals

This publication has 40 references indexed in Scilit:

• Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells
  American Journal of Physiology-Endocrinology and Metabolism, 2004
• Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase‐2 (COX‐2) expression
  International Journal of Cancer, 2004
• Up-regulation of p21 Gene Expression by Peroxisome Proliferator-Activated Receptor γ in Human Lung Carcinoma Cells
  Clinical Cancer Research, 2004
• Suppression of prostaglandin E2 receptor subtype EP2 by PPARγ ligands inhibits human lung carcinoma cell growth
  Biochemical and Biophysical Research Communications, 2004
• Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference
  Oncogene, 2003
• Cyclooxygenase‐2: A novel molecular target for the prevention and treatment of head and neck cancer
  Head & Neck, 2002
• Inhibitory effect of a selective cyclooxygenase‐2 inhibitor on liver metastasis of colon cancer
  International Journal of Cancer, 2002
• The MEK/ERK pathway mediates COX‐2‐selective NSAID‐induced apoptosis and induced COX‐2 protein expression in colorectal carcinoma cells
  International Journal of Cancer, 2002
• PPARγ ligands suppress proliferation of human urothelial basal cells in vitro
  Journal of Cellular Physiology, 2002
• INHIBITION OF COX-2 AND INDUCTION OF APOPTOSIS: Two Determinants of Nonsteroidal Anti-Inflammatory Drugs' Chemopreventive Efficacies in Mouse Lung Tumorigenesis
  Experimental Lung Research, 2000